
UTI-BSE Sensex Next 50 ETF
ETFs FundNAV
88.51(-1.48%)Fund Size (CR)
₹26.24Expense Ratio
0.2Scheme Type
Passive FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹0Minimum SIP Investment
₹undefinedMinimum Withdrawal
₹0Exit Load
0%Return Since Launch
17.00%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Sharwan Kumar Goyal
Bench Mark
BSE SENSEX Next 50 Index TRI
Type
OPEN
Lumpsum Returns
Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 18 August 2025 | 10089.34 | 0.89% | - | 0.60% | 74/277 |
1 Month | 25 July 2025 | 10116.85 | 1.17% | - | 0.62% | 92/272 |
3 Month | 23 May 2025 | 10180.54 | 1.81% | - | 2.81% | 105/260 |
6 Month | 25 February 2025 | 11598.73 | 15.99% | - | 11.67% | 47/238 |
1 Year | 23 August 2024 | 9924.82 | -0.75% | -0.75% | 5.88% | 153/219 |
3 Year | 25 August 2022 | 17381.12 | 73.81% | 20.21% | 16.73% | 39/142 |
5 Year | 25 August 2020 | 28932.81 | 189.33% | 23.66% | 17.74% | 9/87 |
Since Inception | 8 March 2019 | 27622.27 | 176.22% | 17.00% | 14.17% | 65/277 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 2 September 2024 | 1,20,000 | 122944.21 | 2.45% | 2.45% |
3 Year | 1 September 2022 | 3,60,000 | 477523.72 | 32.65% | 9.87% |
5 Year | 1 September 2020 | 6,00,000 | 836352.35 | 39.39% | 6.87% |
10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.58%
Standard Deviation
1.18%
Beta
0.94%
Sharpe Ratio
-0.02%
Treynor's Ratio
6.96%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
---|---|---|---|---|---|
Max Healthcare | 3.48% | 7345 | 0.91 | Equity | Healthcare |
Divi's Lab. | 3.19% | 1267 | 0.84 | Equity | Pharmaceuticals |
HDFC Life Insur. | 3.08% | 10704 | 0.81 | Equity | Insurance |
Vedanta | 2.71% | 16715 | 0.71 | Equity | Mining & Mineral products |
Varun Beverages | 2.68% | 13447 | 0.70 | Equity | FMCG |
Suzlon Energy | 2.61% | 111258 | 0.69 | Equity | Capital Goods - Electrical Equipment |
Britannia Inds. | 2.58% | 1173 | 0.68 | Equity | FMCG |
Tata Power Co. | 2.50% | 16518 | 0.66 | Equity | Power Generation & Distribution |
Indian Hotels Co | 2.48% | 8773 | 0.65 | Equity | Hotels & Restaurants |
TVS Motor Co. | 2.47% | 2314 | 0.65 | Equity | Automobile |
Peer Comparison
Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|
List of Schemes under UTI Mutual Fund
News
UTI Mutual Fund announces change in Exit Load Structure
UTI Mutual Fund has announced change in exit load structure under following scheme stands revised with effect from 06 August 2025Change in Exit Load:
Name of the Scheme Existing exit load (as % of NAV) Revised exit load (as % of NAV) UTI Balanced Advantage Fund (A)Redemption / Switch out within 12 months from the date of allotment '
(i) upto 10% of the allotted Units ' NIL
(ii) beyond 10% of the allotted Units - 1.00 %
(B) Redemption / Switch out after 12 months from the date of allotment ' NIL(A) Redemption / Switch out within 90 days from the date of allotment' 1.00%
(B) Redemption / Switch out after 90 days from the date of allotment ' NILPowered by Capital Market - Live News
UTI Aggressive Hybrid Fund announces Income Distribution cum Capital Withdrawal (IDCW)
UTI Mutual Fund has announced 07 August 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) under IDCW-Regular Plan and IDCW-Direct Plan of UTI Aggressive Hybrid Fund. The quantum of dividend will be Rs 0.9000 per unit or 9.00% on the face value of Rs 10 per unit.Powered by Capital Market - Live News
UTI Mutual Fund announces change in Key Personnel
UTI Mutual Fund has announced the appointment of Ms. Gayatri Kannan as Vice President & Compliance Officer on the Board of the Trustee Company with effect from August 01, 2025:Details of Ms. Gayatri Kannan
Age: 34 years
Designation: Vice President & Compliance Officer
Qualification: Chartered Accountant, Company Secretary, FRM (GARP US), B. Com
Experience: 8 years
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
26 February 2019
Total AUM (Cr)
₹26.24
UTI-BSE Sensex Next 50 ETF is an ETFs Fund-oriented fund from the renowned AMC, UTI Mutual Fund. Launched in 26 February 2019, this fund is managed by Sharwan Kumar Goyal. With assets under management (AUM) worth ₹26.24 (Cr), as of 26 August 2025, UTI-BSE Sensex Next 50 ETF is categorized as a ETFs Fund within its segment. The fund has generated a return of 17.00% since its launch.
The current NAV of UTI-BSE Sensex Next 50 ETF is ₹88.51, as on 26 August 2025. The fund's benchmark index is BSE SENSEX Next 50 Index TRI. You can invest in UTI-BSE Sensex Next 50 ETF via both lumpsum and SIP modes. The minimum SIP amount in the fund is - while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
Nil The fund has generated 20.21% and 23.66% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 99.85% in Equity, 0.17% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 9.22% in Banks, 8.71% in Finance, 6.05% in IT-Software, 5.34% in Power, 4.96% in Pharmaceuticals & Biotech